Pharmaceuticals: Why ad spending’s ailing
March 28, 2013
A number of ad categories have increased spending over the past few years following deep declines during the height of the recession.
Pharmaceuticals is not one of them.
Even as positive economic news builds, including a decrease in the unemployment rate, an increase in home building starts and a surge in the stock market, drug companies have reigned in their ad budgets.
Unlike many other categories, such as automotive and retail, pharmaceutical spending is tied not so much to the economy as to the state of the industry itself, and right now the mood is one of extreme caution.
Last year GlaxoKlineSmith reached a $3 billion settlement with the Justice Department over the marketing and development of its drugs. The government accused the British company of, among other things, advertising its drugs to treat ailments they were not approved for.
“Overall the business in the past several years has taken a more cautious approach to marketing in response to fears about regulation,” notes Jon Swallen, chief research officer at Kantar Media North America.
No one wants to be the next GlaxoKlineSmith, and in response many companies have pulled back on their advertising.
Last year spending in the category declined 3.8 percent, according to data crunched by Kantar and Nomura, from $7.6 billion to $7.31 billion.
It was the third-biggest decline for any top-20 ad category, behind only office supplies (down 10.3 percent) and media and entertainment (down 4.2 percent).
No individual pharmaceutical advertiser finished among the top 10 for 2012, according to Kantar. Pfizer was among the top seven until 2011.
Pharmaceutical advertising has dropped sharply in magazines as well as spot television, where spending plunged 30 percent last year, according to the TVB.
The other issue holding back spending is that there hasn’t been a major new drug introduction in some years. With no major new drugs to promote, pharmaceutical companies have little reason to increase spending.
In the past, rollouts of drugs such as Viagra, Lipitor and Zoloft have triggered a huge amount of ad spending to familiarize the public with the purpose and benefits of the new medications.
“Part of the reason is there have not been any big blockbuster marketing launches for newly approved drugs,” Swallen says.
“That was traditionally the catalyst during the last half of the past decade, 2005 to 2010. The category was propelled by marketing introductions.”
And with no major introductions on the horizon, the pharmaceutical ad chill could last for years to come.
‘Idol’ fuels Fox past CBS on Thursday
Readers: Expect a record Super Bowl, again
Our rising national obsession with sports
The high cost of ads for the Super Bowl ads
How football stacks up among Hispanics
Rachel, need I go back to school for media?
Weekend TV: The Super Bowl edition
Cable overnights: Another Warriors victory
So-so turnout for ‘Madoff’ miniseries
Sumner Redstone steps down at Viacom, too
Programming blog: What’s canceled and renewed
Denver: Bonkers for Broncs’ big game
What’s hot and not for Super Bowl ads
- Ed Castillo becomes global chief strategy officer at Arnold
- Juan Cruz Vassallo becomes associate creative director at the community
- Robert Cappuccino becomes VP of national sales at Foundations Marketing
- Simon White becomes chief strategy officer at FCB West
- Lynn Eastep becomes president at Fathom
- James Bennet becomes president at ASME
- Andrew Edwards becomes director of digital intelligence at Cardinal Path
- Marc Ferrentino becomes EVP of strategy at Yext
- Matt LeBlanc becomes co-host on BBC's 'Top Gear'
- Isabella Rossellini joins the cast of Hulu's 'Shut Eye'
- Seal joins the cast of Fox’s ‘The Passion’
- Dan Stevens, Aubrey Plaza and Jean Smart join FX’s ‘Legion’
This week’s broadcast ratings
This week’s cable ratings
This week’s top movies, songs and books
This week’s daypart ratings
This month’s new media traffic data
This week’s younger viewer ratings
Digital content manager opening in Atlanta
Senior media planner wanted in Des Moines
Media planner/buyer position in Cincinnati
Looking for a media strategist in Cincinnati
Opening for a marketing communications manager